Hartford Investment Management CO Teva Pharmaceutical Industries LTD Transaction History

Hartford Investment Management CO

$2.99 Billion
Q4 2024

A detailed history of Hartford Investment Management CO transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Hartford Investment Management CO holds 10,588 shares of TEVA stock, worth $180,631. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,588

Previous 10,562 0.25%

Holding current value

$180,631

Previous $190,000 22.63%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	BUY	$16.43 - $22.77 $427 - $592	26 Added 0.25%	10,588 $233,000
Q3 2024 Oct 22, 2024	BUY	$15.81 - $18.96 $806 - $966	51 Added 0.49%	10,562 $190,000
Q2 2024 Aug 01, 2024	BUY	$12.78 - $17.4 $2,300 - $3,131	180 Added 1.74%	10,511 $170,000
Q1 2024 Apr 17, 2024	BUY	$10.67 - $14.43 $106 - $144	10 Added 0.1%	10,331 $145,000
Q3 2023 Oct 16, 2023	BUY	$7.48 - $10.7 $1,525 - $2,182	204 Added 2.02%	10,321 $105,000
Q2 2023 Jul 19, 2023	BUY	$7.2 - $9.47 $72,842 - $95,807	10,117 New	10,117 $76,000
Q2 2022 Jul 22, 2022	SELL	$7.38 - $10.4 $154 - $218	-21 Reduced 0.16%	13,006 $98,000
Q1 2022 Apr 20, 2022	SELL	$7.33 - $9.39 $51,925 - $66,518	-7,084 Reduced 35.22%	13,027 $122,000
Q4 2021 Feb 02, 2022	SELL	$7.9 - $10.19 $1,335 - $1,722	-169 Reduced 0.83%	20,111 $161,000
Q3 2021 Nov 01, 2021	SELL	$8.38 - $10.18 $25,517 - $30,998	-3,045 Reduced 13.05%	20,280 $198,000
Q2 2021 Jul 29, 2021	SELL	$9.9 - $11.56 $4,286 - $5,005	-433 Reduced 1.82%	23,325 $231,000
Q1 2021 Apr 21, 2021	SELL	$10.34 - $12.81 $25,653 - $31,781	-2,481 Reduced 9.46%	23,758 $274,000
Q4 2020 Feb 01, 2021	SELL	$8.61 - $11.04 $77 - $99	-9 Reduced 0.03%	26,239 $253,000
Q3 2020 Oct 29, 2020	SELL	$8.57 - $12.69 $5,990 - $8,870	-699 Reduced 2.59%	26,248 $236,000
Q2 2020 Aug 04, 2020	BUY	$8.12 - $13.12 $1,859 - $3,004	229 Added 0.86%	26,947 $332,000
Q1 2020 Apr 24, 2020	BUY	$6.69 - $13.45 $2,789 - $5,608	417 Added 1.59%	26,718 $240,000
Q4 2019 Jan 29, 2020	SELL	$6.53 - $10.72 $10,043 - $16,487	-1,538 Reduced 5.52%	26,301 $258,000
Q3 2019 Oct 28, 2019	SELL	$6.16 - $9.6 $2,987 - $4,656	-485 Reduced 1.71%	27,839 $192,000
Q2 2019 Jul 25, 2019	BUY	$8.12 - $15.72 $14,193 - $27,478	1,748 Added 6.58%	28,324 $261,000
Q1 2019 Apr 29, 2019	SELL	$15.58 - $20.01 $46,817 - $60,130	-3,005 Reduced 10.16%	26,576 $417,000
Q4 2018 Feb 04, 2019	BUY	$14.59 - $23.84 $13,160 - $21,503	902 Added 3.15%	29,581 $456,000
Q3 2018 Nov 08, 2018	SELL	$21.06 - $25.65 $24,219 - $29,497	-1,150 Reduced 3.86%	28,679 $618,000
Q2 2018 Jul 19, 2018	BUY	$16.77 - $24.71 $29,464 - $43,415	1,757 Added 6.26%	29,829 $725,000
Q1 2018 Apr 24, 2018	SELL	$16.68 - $22.07 $49,739 - $65,812	-2,982 Reduced 9.6%	28,072 $480,000
Q4 2017 Feb 12, 2018	SELL	$11.23 - $19.1 $1,145 - $1,948	-102 Reduced 0.33%	31,054 $588,000
Q3 2017 Nov 13, 2017	BUY	$15.41 - $32.17 $480,113 - $1 Million	31,156	31,156 $548,000

Others Institutions Holding TEVA

# of Institutions

638

Shares Held

580M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Account

Hartford Investment Management CO Teva Pharmaceutical Industries LTD Transaction History